Why The Johnson & Johnson Vaccine Has Gotten A Bad Rap — And Why That's Not Fair (1 Viewer)

< Previous | Next >

Ari Shapiro

Guest
Offline


Two COVID-19 vaccines are being distributed in the U.S. right now, and this week an FDA advisory committee will vote on whether a third should join them.

If granted emergency use authorization, Johnson & Johnson's one-dose vaccine would become available in the U.S., along with those from Pfizer and Moderna.

In clinical trials, the Johnson & Johnson vaccine appears to be 66% effective at preventing moderate to severe cases of COVID-19 — compared to about 95% for Moderna and Pfizer. That has some people wondering if they should avoid the Johnson &...

Continue reading...
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

< Previous | Next >

Users Who Are Viewing This Thread (Users: 0, Guests: 1)

Advertisement

Sponsored

Top Bottom